- Report
- August 2022
- 40 Pages
India
From €1490EUR$1,500USD£1,239GBP
- Report
- August 2022
- 100 Pages
Global
From €2484EUR$2,500USD£2,065GBP
- Report
- April 2022
- 40 Pages
United States
From €1490EUR$1,500USD£1,239GBP
- Report
- December 2021
- 100 Pages
Global
From €2484EUR$2,500USD£2,065GBP
- Report
- November 2021
- 40 Pages
India
From €1490EUR$1,500USD£1,239GBP
- Report
- November 2021
- 40 Pages
Saudi Arabia
From €1490EUR$1,500USD£1,239GBP
- Report
- July 2021
- 40 Pages
India
From €1490EUR$1,500USD£1,239GBP
- Report
- April 2021
- 100 Pages
Global
From €2484EUR$2,500USD£2,065GBP
- Report
- October 2024
- 70 Pages
China
From €944EUR$950USD£785GBP
- Report
- October 2024
- 70 Pages
France
From €944EUR$950USD£785GBP
- Report
- October 2024
- 70 Pages
Germany
From €944EUR$950USD£785GBP
- Report
- October 2024
- 70 Pages
India
From €944EUR$950USD£785GBP
- Report
- October 2024
- 70 Pages
United Kingdom
From €944EUR$950USD£785GBP
- Report
- November 2023
- 78 Pages
From €2931EUR$2,950USD£2,437GBP
- Report
- September 2023
- 31 Pages
Global
From €4962EUR$4,995USD£4,126GBP
- Report
- September 2023
- 73 Pages
Global
From €4962EUR$4,995USD£4,126GBP
- Report
- September 2023
- 83 Pages
Global
From €4962EUR$4,995USD£4,126GBP
- Report
- September 2023
- 393 Pages
Global
From €9929EUR$9,995USD£8,256GBP
- Report
- July 2023
- 695 Pages
Europe
From €8936EUR$8,995USD£7,430GBP
- Report
- July 2023
- 179 Pages
Global
From €3800EUR$3,825USD£3,159GBP
€4471EUR$4,500USD£3,717GBP
The Infusions and Injectables market is a segment of the pharmaceutical industry that focuses on the production and distribution of drugs that are administered through intravenous (IV) or intramuscular (IM) injections. These drugs are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases. The market is highly competitive, with a number of large pharmaceutical companies vying for market share.
The market is divided into two main segments: branded and generic drugs. Branded drugs are typically more expensive than generic drugs, but they are often more effective and have fewer side effects. Generic drugs are typically cheaper, but they may not be as effective or have as many side effects.
Some of the major players in the Infusions and Injectables market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. These companies are responsible for the production and distribution of a wide range of drugs, including cancer treatments, diabetes medications, and autoimmune therapies. Show Less Read more